<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study was designed to determine the potential role of survivin in the pathogenesis of BurkittÂ´s <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and analyzing the relationship of its expression with response to therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of survivin was investigated in seven archival <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> using the streptavidin-<z:chebi fb="1" ids="15956">biotin</z:chebi> complex technique </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical analysis showed that survivin expression was positive in 6 of 7 BL cases (85.7%) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> group with high survivin expression had poor response to chemotherapy than the group with low survivin expression (P=0.005) </plain></SENT>
<SENT sid="4" pm="."><plain>The results suggest that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibition by survivin is a significant prognostic parameter of poor response to chemotherapy in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>